Pioneers in cancer care

The Aktis Oncology team is pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumors.

Leadership Team

Matthew Roden, PhD

Matthew Roden, PhD

Matthew Roden, PhD

President,
Chief Executive Officer

Tyler Benedum, PhD

Tyler Benedum, PhD

Tyler Benedum, PhD

Chief Technical Officer

Akos Czibere, MD, PhD

Chief Medical Officer

Paul L. Feldman, PhD

Paul L. Feldman, PhD

Paul L. Feldman, PhD

Chief Scientific Officer

Kyle Kuvalanka

Kyle Kuvalanka

Kyle Kuvalanka

Chief Financial Officer

Shulamit Ron-Bigger, PhD

Shulamit Ron-Bigger, PhD

Shulamit Ron-Bigger, PhD

Chief Operating Officer

R&D Leaders

Lorraine Horgan

Lorraine Horgan

Lorraine Horgan

Vice President,
Head of Program Management

Janet Horton, MD

Janet Horton, MD

Janet Horton, MD

Vice President,
Clinical Development

Jeff Kovacs, PhD

Jeff Kovacs, PhD

Jeff Kovacs, PhD

Vice President,
Head of Biology

Daša Lipovšek, PhD

Daša Lipovšek, PhD

Daša Lipovšek, PhD

Vice President,
Head of Lead Discovery

Yuan Xue, PhD

Yuan Xue, PhD

Yuan Xue, PhD

Vice President,
Head of Regulatory Affairs

Nate Demars

Nate Demars

Nate Demars

Executive Director,
Head of Clinical Operations

Stanley Krystek, PhD

Stanley Krystek, PhD

Stanley Krystek, PhD

Executive Scientific Director

Tiffany Wang, MD, MBA, MS

Tiffany Wang, MD, MBA, MS

Tiffany Wang, MD, MBA, MS

Executive Director,
Clinical Development

Business Leaders

Karen McCarthy

Karen McCarthy

Karen McCarthy

Vice President,
Head of Finance

Carlos Rodriguez

Carlos Rodriguez

Carlos Rodriguez

Executive Director,
Corporate Development

CMC and Quality Leaders

Judit Bartis, PhD

Judit Bartis, PhD

Judit Bartis, PhD

Vice President,
CMC Operations

Timothy I. Mitchell

Timothy I. Mitchell

Timothy I. Mitchell

Vice President,
Quality Assurance

Tom Morley, PhD

Tom Morley, PhD

Tom Morley, PhD

Executive Director,
Radiopharmaceutical Development

Board of Directors

Todd Foley

Co-founder and Chairman

Ken Herrmann, MD

Independent Director Chair, Scientific Advisory Board

Helen Kim, MBA

Director

Oleg Nodelman

Director

Matthew Roden, PhD

Director

Lloyd M. Segal, MBA

INDEPENDENT DIRECTOR

Mike Sherman

Independent Director

Mary Thistle

Independent Director

Scientific Advisors

Ken Herrmann, MD

Independent Director Chair, Scientific Advisory Board

Patrick Baeuerle, PhD

Co-founder & Advisor

Pankaj Bhargava, MD

Advisor

Erik Chelius, PhD

Advisor

Johannes Czernin, MD

Advisor

Germo Gericke, MD

Advisor

Gary Glick, PhD

Advisor

Dane Wittrup, PhD

Advisor

Join us

Join a team dedicated to discovering and developing transformative therapies that put solid cancers into remission.

Scientist in lab coat working at computer desk